Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,430 public trials 2,855 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)

NCT02232906

Conditions: Anaemia, Anemia, Chronic Disease, +18 more
Locations: Hospital Alemán Buenos Aires, Argentina

View Trial Details

Completed

Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

NCT02232113

Conditions: Anemia, Disease, Hematologic Diseases, +8 more
Locations: Taipei Veterans General Hospital Taipei, Taiwan

View Trial Details

Completed

Beta-thalassemia and Microparticles

NCT01284738

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +10 more
Locations: APHM Marseille, France

View Trial Details

Completed

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

NCT00275080

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
Locations: Chedoke-McMaster Hospitals Hamilton, Ontario, Canada

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload

NCT00600938

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +24 more
Locations: Novartis Investigative Site Toronto, Ontario, Canada

Novartis Investigative Site Nanning, Guangxi, China

Novartis Investigative Site Limassol, Cyprus

Novartis Investigative Site Al Mansurah, Egypt

View all 21 locations

View Trial Details

Completed

Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period

NCT01328704

Conditions: Anemia, Avitaminosis, Deficiency Diseases, +9 more
Locations: Avera Sports Institute Sioux Falls, South Dakota, United States

View Trial Details

Completed

Imaging Young Myeloma (IMAgerie JEune Myélome)

NCT01309334

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Bordeaux University Hospital Bordeaux, France

Brest University Hospital "CHU du Morvan" Brest, France

Hospital "Côte de Nacre" Caen, France

Clermont-Ferrand University Hospital Clermont-Ferrand, France

View all 17 locations

View Trial Details